Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

96.59
Delayed Data
As of Feb 05
 -0.35 / -0.36%
Today’s Change
69.33
Today|||52-Week Range
263.81
-4.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
AssetsCash322.6M12.2B958.0M1.4B
 
 
 
 
 
Short Term Investment Cash-479.1M1.5B-903.5M409.6M
 
 
 
 
 
Cash & Short Term Investments322.6M12.2B958.0M1.4B
 
 
 
 
 
 
ReceivablesReceivables2.1B2.1B2.4B2.7B
 
 
 
 
 
 
InventoriesInventories950.6M998.9M1.2B1.2B
 
 
 
 
 
 
Current AssetsOther Current Assets844.1M865.2M1.8B1.7B
 
 
 
 
 
Current Assets4.2B16.2B6.3B7.0B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.3B1.3B1.4B1.4B
 
 
 
 
 
Depreciation-977.9M------
 
 
Intangible Assets20.6B20.7B40.4B39.8B
 
 
 
 
 
Other Assets20.8B20.9B40.5B40.0B
 
 
 
 
 
Total Assets26.4B38.6B48.3B48.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable398.0M352.5M415.8M476.8M
 
 
 
 
 
Short Term Debt7.1M122.8M590.9M707.0M
 
 
 
 
 
Accrued Expenses258.7M2.4B3.1B3.3B
 
 
 
 
 
Other Current Liabilities2.0B2.6B3.2B3.5B
 
 
 
 
 
Other Liabilities2.7B3.1B4.3B4.7B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt15.3B25.9B30.3B30.2B
 
 
 
 
 
Deferred Taxes-2.2B-2.1B-6.1B-5.9B
 
 
 
 
 
Other Liabilities466.7M407.8M723.2M809.3M
 
 
 
 
 
Total Liabilities20.9B32.0B41.8B42.0B
 
 
 
 
 
 
EquityMinority Interest-800.0K-800.0K-1.4M-2.2M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity5.3B6.5B6.4B6.3B
 
 
 
 
 
Total Shareholder Equity5.3B6.5B6.4B6.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding334.4M342.3M342.8M343.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.